University of Cambridge researchers have created the first AI-designed vaccine aimed at providing broad protection against multiple coronavirus variants. By using AI to engineer a synthetic “super-antigen,” the team hopes to preempt viral evolution. An initial safety trial with 39 volunteers showed promise, with larger studies now planned to test efficacy against future threats.